SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

KeyBanc Raises ResMed Price Target to $277 From $267

KeyBanc maintained ResMed at Overweight, according to Benzinga.

RMD

Related stories